Impact of benralizumab on asthma control, asthma-related quality of life and lung function in patients with poorly controlled eosinophilic asthma: A systematic review and meta-analysis
2018
AbstractBACKGROUND: Benralizumab is a monoclonal antibody to the alpha subunit of the IL-5 receptor used in the management of severe, eosinophilic asthma. Although Benralizumab has been shown to si...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
0
Citations
NaN
KQI